TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biogen Norway AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
287,946
|
253,925
|
284,385 |
| Financial expenses |
1
|
15
|
232 |
| Earnings before taxes |
15,476
|
12,192
|
9,564 |
| Total assets |
233,915
|
210,748
|
198,402 |
| Current assets |
233,698
|
210,567
|
198,142 |
| Current liabilities |
48,696
|
37,593
|
34,740 |
| Equity capital |
185,219
|
173,155
|
163,662 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
9
|
19
|
26 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
79.2%
|
82.2%
|
82.5% |
| Turnover per employee |
31,994
|
13,364
|
10,938 |
| Profit as a percentage of turnover |
5.4%
|
4.8%
|
3.4% |
| Return on assets (ROA) |
6.6%
|
5.8%
|
4.9% |
| Current ratio |
479.9%
|
560.1%
|
570.4% |
| Return on equity (ROE) |
8.4%
|
7.0%
|
5.8% |
| Change turnover |
34,021
|
-30,460
|
-101,044 |
| Change turnover % |
13%
|
-11%
|
-26% |
| Chg. No. of employees |
-10
|
-7
|
7 |
| Chg. No. of employees % |
-53%
|
-27%
|
37% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.